WAT

Q: What is the price of Waters (WAT) today?

The current price of Waters (WAT) is $ 309.80, representing a -8.31% gain over the past year. The stock began the year trading around $ 379.83 and is currently priced at $ 309.80. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Waters (WAT) pay dividends?

Waters (WAT) did not pay dividends over the past year.

Q: Is Waters (WAT) a good investment?

Waters (WAT) is currently trading at $ 309.80 with a P/E ratio of 30.60%. This represents a 3,101% premium compared to its historical average P/E. Over the past year, the stock has gained -8.31 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -8.31%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Waters Corporation

Price

$ 309.80

return (12m)

-8.31%

p/e

30.60

p/bv

7.68

DIVIDEND YIELD

0.00%

WAT price

WAT

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment WAT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.07%

3 months

-21.03%

1 year

-8.31%

2 years

0.47%

5 years

1.82%

10 years

135.32%

Fundamentals WAT

review the fundamentals of Waters shares

P/E

30.60

Sector: -3.97 Industry: -4.31

P/S (PSR)

6.21

Sector: 1.88 Industry: 0.63

P/BV

7.68

Sector: 2.15 Industry: 1.33

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

12.64%

Sector: -29.79% Industry: -19.07%

ROE

25.09%

Sector: -35.24% Industry: -14.51%

ROIC

21.17%

Sector: -417.02% Industry: -113.78%

NET MARGIN

20.30%

Sector: -31.19% Industry: -20.37%

GROSS MARGIN

59.28%

Sector: 43.22% Industry: 28.66%

OPERATING MARGIN

25.36%

Sector: -26.40% Industry: -11.84%

EV/EBITDA

19.19

Sector: -1.86 Industry: -0.70

EV/EBIT

24.02

Sector: -3.23 Industry: 1.04

PRICE-TO-ASSETS

3.87

Sector: 1.12 Industry: 0.75

BVPS

42.69

Sector: 3.46 Industry: 5.18

EPS

10.71

Sector: -1.05 Industry: -0.80

EQUITY-TO-ASSETS RATIO

0.50

Sector: 0.41 Industry: 0.26

LIABILITIES / ASSETS

0.50

Sector: 0.45 Industry: 0.44

CAGR REVENUE 5 YEARS

2.59%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-1.49%

Sector: - Industry: -

FAIR VALUE OF Waters ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 309.80

Fair Value

$ 0.00

Upside/Downside Return potential.

-67.26%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals WAT

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.20	34.79	86.53%	0.67%	$ 829.69 B	31.66%
ISRG	57.46	9.73	16.93%	0.00%	$ 171.19 B	28.15%
NVS	20.81	6.25	30.04%	4.59%	$ 291.02 B	24.67%
SNY	12.86	1.40	10.86%	4.60%	$ 117.31 B	18.68%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	23.97	2.25	9.38%	3.30%	$ 110.58 B	13.00%
GSK	15.37	5.49	35.71%	3.00%	$ 117.24 B	17.48%
CVS	55.53	1.30	2.35%	3.44%	$ 98.17 B	0.44%
BSX	25.86	0.00	0.00%	0.00%	$ 92.17 B	17.29%
TMDX	20.70	8.33	40.22%	0.00%	$ 3.94 B	31.43%
IDXX	42.73	28.20	65.99%	0.00%	$ 45.27 B	24.62%
RMD	22.41	5.27	23.51%	1.02%	$ 33.31 B	27.53%
INMD	9.67	1.33	13.73%	0.00%	$ 907.20 M	25.32%
PHG	27.23	2.20	8.06%	2.98%	$ 28.25 B	5.07%
FMS	11.87	0.80	6.75%	3.36%	$ 13.40 B	5.02%
SYK	40.51	5.86	14.48%	0.99%	$ 131.49 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

WAT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Waters

Waters Corporation

Average Investor10 user rating

4.0 (5 people)

United States

35 years

Founded: 1991

1995

Time since IPO - 31 years

7.500

Employees

Waters Corporation (United States) is listed on the NYSE and has a market capitalization of $19.67 Billions, with shareholders equity totaling $2.56 Billions.

The company employs approximately 7.500 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Waters Corporation reported $3.17 Billions in revenue, generating net income of $642.62 Millions.

Key financial metrics include a P/E ratio of 30.60, a price-to-book (P/B) ratio of 7.68, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker WAT.

Market cap

$ 19.67 Billions

Net worth

$ 2.56 Billions

$ 2,561,240,000.00

Assets

$ 5.08 Billions

$ 5,083,980,000.00

Total Shares Outstanding

60.00 Millions

60,000,000

Average Daily Trading Volume

$ 1.29 Million

$ 1,289,682.44

Sector

Health

Industry

Life Science Tools and Services

WAT

revenue by Business Segment Waters

Revenue by Region Waters

WAT revenue and profits

Financial Results WAT

DRAG THE FRAME TO SEE MORE DATA

WAT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.94 24,95% (12M)

P/E

55.53

3.44%

ROE

2.35%

P/BV

1.30

CI - Cigna

$ 275.64 --16,07% (12M)

P/E

10.79

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 41.82 --27,51% (12M)

P/E

-2.81

0.00%

ROE

-33.28%

P/BV

0.94

HUM - Humana

$ 215.23 --17,31% (12M)

P/E

20.72

1.73%

ROE

6.70%

P/BV

1.39

LLY - Eli Lilly

$ 883.96 1,49% (12M)

P/E

40.20

0.67%

ROE

86.53%

P/BV

34.79

NVS - Novartis

$ 145.42 32,22% (12M)

P/E

20.81

4.59%

ROE

30.04%

P/BV

6.25

GSK - GlaxoSmithKline

$ 54.44 51,23% (12M)

P/E

15.37

3.00%

ROE

35.71%

P/BV

5.49